Abstract
Cancer is a global health issue affecting people of all ages. Cancer affecting the women is increasing due to altered life patterns, environmental stress and differences in metabolic activity, and individual physiology. Cervical cancer (CC) which affects the cervix is one of the most common diseases affecting the women and almost 99% of all CC cases are linked to human papillomavirus (HPV) contracted via sexual activity. Early diagnosis of CC is treatable and can be managed effectively even in the advanced stages with appropriate therapeutic strategy. With the scientific advancement there are three different vaccines that have been prequalified and provide protection against HPV-associated CC (Stelzle et al., Lancet Glob Health 9:e161–e169, 2021). Symptoms of CC include irregular bleeding between periods, postmenopausal spotting or bleeding, and increased vaginal discharge. In advanced stages of the disease symptoms like pelvic pain, reduction of body weight, reduced food intake, and edema of lower extremities can be manifested. WHO’s goal is to eliminate this global health issue of CC by 2030 among the low and lower middle class income countries (WHO, United Nations Gen Assem 2:1–3, 2020).
Similar content being viewed by others
References
Agarwal SM, Raghav D, Singh H, Raghava GPS (2011) CCDB: a curated database of genes involved in cervix cancer. Nucleic Acids Res 39:D975. https://doi.org/10.1093/NAR/GKQ1024
Arbyn M, Weiderpass E, Bruni L et al (2020) Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 8:e191–e203. https://doi.org/10.1016/S2214-109X(19)30482-6
Bhatla N, Tomar S, Meena J et al (2021) Adjuvant treatment in cervical, vaginal and vulvar cancer. Best Pract Res Clin Obstet Gynaecol. https://doi.org/10.1016/J.BPOBGYN.2021.07.005
Borges BES, de Brito EB, Fuzii HT et al (2018) Human papillomavirus infection and cervical cancer precursor lesions in women living by Amazon rivers: investigation of relations with markers of oxidative stress. Einstein (Sao Paulo) 16:eAO4190. https://doi.org/10.1590/S1679-45082018AO4190
Bosch FX, Lorincz A, Muñoz N et al (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–265. https://doi.org/10.1136/JCP.55.4.244
Bray F et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries 68(6):394–424. https://doi.org/10.3322/caac.21492
Burk RD, Chen Z, Saller C et al (2017) Integrated genomic and molecular characterization of cervical cancer. Nature 543:378–384. https://doi.org/10.1038/nature21386
Chida Y, Hamer M, Wardle J, Steptoe A (2008) Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol 58(5):466–475. https://doi.org/10.1038/ncponc1134
Clifford GM, Rana RK, Franceschi S et al (2005) Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomark Prev 14:1157–1164. https://doi.org/10.1158/1055-9965.EPI-04-0812
Diouf D, Diop G, Fall C et al (2020) The Association of Molecular Biomarkers in the diagnosis of cervical pre-cancer and cancer and risk factors in Senegalese. Asian Pac J Cancer Prev 21:3221–3227. https://doi.org/10.31557/APJCP.2020.21.11.3221
Fan Y, Shen Z (2018) The clinical value of HPV E6/E7 and STAT3 mRNA detection in cervical cancer screening. Pathol Res Pract 214:767–775. https://doi.org/10.1016/J.PRP.2018.02.003
Gutiérrez-Hoya A, Zerecero-Carreón O, Valle-Mendiola A et al (2019) Cervical cancer cells express markers associated with immunosurveillance. https://doi.org/10.1155/2019/1242979
Hashiguchi M, Nakao Y, Honda A et al (2019) What has changed since the introduction of human papillomavirus testing with the cytology-based cervical cancer screening system in Japan a social experiment. Acta Cytol 63:385–390. https://doi.org/10.1159/000500190
Hoppenot C, Stampler K, Dunton C (2012) Cervical cancer screening in high-and low-resource countries: implications and new developments. Obstet Gynecol Surv 67:658–667
Huang H, Quan Y, Qi X, Liu P (2021) Neoadjuvant chemotherapy with paclitaxel plus cisplatin before radical surgery for locally advanced cervical cancer during pregnancy: a case series and literature review. Medicine (Baltimore) 100:e26845. https://doi.org/10.1097/MD.0000000000026845
Khunnarong J, Bunyasontikul N, Tangjitgamol S (2021) Treatment outcomes of patients with cervical intraepithelial neoplasia or invasive carcinoma who underwent loop electrosurgical excision procedure. World J Oncol 12:111–118. https://doi.org/10.14740/WJON1391
Klaunig JE, Kamendulis LM (2004) The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 44:239–267. https://doi.org/10.1146/annurev.pharmtox.44.101802.121851
Koudriavtseva T, Lorenzano S, Anelli V et al (2021) Case report: probable cerebral amyloid angiopathy-related inflammation during bevacizumab treatment for metastatic cervical cancer. Front Oncol 11. https://doi.org/10.3389/FONC.2021.669753
Lodygin D, Epanchintsev A, Menssen A et al (2005) Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res 65(10):4218–4227. https://doi.org/10.1158/0008-5472
Lu D, Andrae B, Valdimarsdóttir U et al (2019) Psychologic distress is associated with cancer-specific mortality among patients with cervical cancer. Cancer Res 79:3965–3972. https://doi.org/10.1158/0008-5472.CAN-19-0116
Malhotra SL (1976) New approaches to the causation and prevention of cancers of epithelial surfaces. Med Hypotheses 2:279–281. https://doi.org/10.1016/S0306-9877(76)80010-2
Maynard S, Schurman S, …, Harboe C, 2009 U (2009) Base excision repair of oxidative DNA damage and association with cancer and aging. academic.oup.com
Mitra AB, Murty VVVS, Li R-G et al (1995) Genetic alterations at 5p15: a potential marker for progression of precancerous lesions of the uterine cervix. JNCI J Natl Cancer Inst 87:742–745. https://doi.org/10.1093/JNCI/87.10.742
Myers ER, McCrory DC, Nanda K et al (2000) Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 151:1158–1171. https://doi.org/10.1093/oxfordjournals.aje.a010166
Naidu M, Suryakar A, … SS-IJ of C, 2007 undefined (2007) Oxidative stress and antioxidant status in cervical cancer patients. Springer 22:140–144
Nakabeppu Y, Sakumi K, Sakamoto K et al (2006) Mutagenesis and carcinogenesis caused by the oxidation of nucleic acids. Biol Chem 387:373–379. https://doi.org/10.1515/BC.2006.050/XML
Narayan G, Arias-Pulido H, Nandula SV et al (2004) Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer. Cancer Res 64:2994–2997. https://doi.org/10.1158/0008-5472.CAN-04-0245
O’Malley DM, Randall LM, Jackson CG et al (2021) RaPiDS (GOG-3028): randomized phase II study of balstilimab alone or in combination with zalifrelimab in cervical cancer. Future Oncol 17:3433–3443. https://doi.org/10.2217/FON-2021-0529
Rao PH, Arias-Pulido H, Lu X-Y et al (2004) Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer 41(4):1–9. https://doi.org/10.1186/1471-2407-4-5
Schottenfeld D, Fraumeni JF (2019) Cancer epidemiology and prevention, 4th edn. Oxford University Press
Sreedevi A, Javed R, Dinesh A (2015) Epidemiology of cervical cancer with special focus on India. Int J Women’s Health 7:405–414. https://doi.org/10.2147/IJWH.S50001
Srivastava S, Shahi UP, Divya A et al (2020) Downregulated expression of WWOX in cervical carcinoma: a case-control study. Int J Mol Cell Med 9:0–0. https://doi.org/10.22088/IJMCM.BUMS.9.4.273
Stelzle D, Tanaka LF, Lee KK et al (2021) Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health 9:e161–e169. https://doi.org/10.1016/S2214-109X(20)30459-9
Ting J, Rositch AF, Taylor SM et al (2015) Worldwide incidence of cervical lesions: a systematic review. Epidemiol Infect 143:225–241. https://doi.org/10.1017/S0950268814001356
Walboomers JMM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19. https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
WHO (2020) Global strategy to accelerate the elimination of cervical cancer as a public health problem and its associated goals and targets for the period 2020–2030. United Nations Gen Assem 2:1–3
Yan P, Yu G, Tseng G et al (2007) Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. AACR 67:8043–8050. https://doi.org/10.1158/0008-5472.CAN-07-0648
Yoshida K, Kondo E, Matsumoto T et al (2021) Laparoscopic retroperitoneal para-aortic lymph node biopsy in advanced cervical cancer with pelvic lymph node metastases: a single-center prospective study. J Obstet Gynaecol Res. https://doi.org/10.1111/JOG.14990
Zhao H, Shao H (2016) Diagnostic value of human papillomavirus E6/E7 mRNA for residue and recurrence after cervical conization. J Cent South Univ (Medical Sci) 41:606–611. https://doi.org/10.11817/J.ISSN.1672-7347.2016.06.009
Zhu L, Zhang X, Sun Z (2020) SNRPB promotes cervical cancer progression through repressing p53 expression. Biomed Pharmacother 125:109948. https://doi.org/10.1016/J.BIOPHA.2020.109948
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2022 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Santosh, S.W., Freddy, A.J., Winkins, D. (2022). Oxidative Stress in the Pathogenesis of Cervical Cancer. In: Chakraborti, S. (eds) Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Springer, Singapore. https://doi.org/10.1007/978-981-16-5422-0_277
Download citation
DOI: https://doi.org/10.1007/978-981-16-5422-0_277
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-5421-3
Online ISBN: 978-981-16-5422-0
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences